Evidence map›Paper›PMID 34205483›Full record

ArticleVaccines2021

COVID-19 Vaccine Acceptance in Azuay Province, Ecuador: A Cross-Sectional Online Survey.

Julio Jaramillo-Monge, Michael Obimpeh, Bernardo Vega, David Acurio, Annelies Boven, Veronique Verhoeven, Robert Colebunders

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julio Jaramillo-MongeFaculty of Health Science, Universidad de Cuenca, Cuenca 010203, Ecuador.ORCID 0000-0002-1710-1778
Michael ObimpehFamily Medicine and Population Health, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0001-7140-4932
Bernardo VegaFaculty of Health Science, Universidad de Cuenca, Cuenca 010203, Ecuador.
David AcurioFaculty of Health Science, Universidad de Cuenca, Cuenca 010203, Ecuador.ORCID 0000-0003-3258-2837
Annelies BovenFamily Medicine and Population Health, University of Antwerp, 2610 Antwerp, Belgium.
Veronique VerhoevenFamily Medicine and Population Health, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0002-3708-6501
Robert ColebundersFamily Medicine and Population Health, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0002-1919-1340
University of Antwerp · BEUniversity of Cuenca · EC

Funding

VLIRUOS (Flemish University development aid 36-7921
6 · The paper itself

Abstract

We investigated the COVID-19 vaccination acceptance level in Azuay province, Ecuador through an online survey from 12th to 26th February (before the start of the COVID-19 vaccination campaign in Ecuador). Overall, 1219 respondents participated in the survey. The mean age was 32 ± 13 years; 693 participants (57%) were female. In total, 1109 (91%) of the participants indicated they were willing to be vaccinated with a COVID-19 vaccine, if the vaccine is at least 95% effective; 835 (68.5%) if it is 90% effective and 493 (40.5%) if it is 70% effective; 676 (55.5%) participants indicated they feared side effects and 237 (19.4%) thought the vaccine was not effective. Older age, having had a postgraduate education, a history of a negative COVID-19 test, a high level of worry of contracting COVID-19, believing that COVID-19 infection can be prevented with a vaccine and understanding there is currently an effective vaccine against COVID-19 were associated with higher vaccination acceptance. A vaccination education campaign will be needed to increase the knowledge of Ecuadorians about the COVID-19 vaccine and to increase their trust in the vaccine. People with a lower education level and living in rural areas may need to be targeted during such a campaign.

Indexed as

COVID-9Ecuadorhesitancyvaccine acceptance

Identifiers

PMID34205483
PMCPMC8235423
OpenAlexW3176853360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.